BR112015015199A2 - composição imunogênica compreendendo antígenos de micoplasma - Google Patents

composição imunogênica compreendendo antígenos de micoplasma

Info

Publication number
BR112015015199A2
BR112015015199A2 BR112015015199A BR112015015199A BR112015015199A2 BR 112015015199 A2 BR112015015199 A2 BR 112015015199A2 BR 112015015199 A BR112015015199 A BR 112015015199A BR 112015015199 A BR112015015199 A BR 112015015199A BR 112015015199 A2 BR112015015199 A2 BR 112015015199A2
Authority
BR
Brazil
Prior art keywords
immunogenic composition
mycoplasma
antigens
hyosynoviae
hyorhinis
Prior art date
Application number
BR112015015199A
Other languages
English (en)
Other versions
BR112015015199B1 (pt
Inventor
V Iyer Arun
Neubauer Axel
Thomas Martinson Brian
Margaret Muehlenthaler Christine
M Murphy Jordan Dianna
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of BR112015015199A2 publication Critical patent/BR112015015199A2/pt
Publication of BR112015015199B1 publication Critical patent/BR112015015199B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Abstract

resumo patente de invenção: "composição imunogênica compreendendo antígenos de micoplasma". a presente invenção refere-se a uma composição imunogênica compreendendo: a) um ou mais antígenos de m. hyorhinis e um ou mais antígenos de m. hyosynoviae; e b) um veículo farmaceuticamente aceitável. além disso, a presente invenção refere-se a uma composição imunogênica compreendendo a) um ou mais antígenos de micoplasma de bactéria micoplasma selecionadas do grupo que consiste em m. hyorhinis, m. hyopneumoniae e m. hyosynoviae; e b) um ou mais componentes de um sistema celular eucariótico. além disso, a presente invenção também fornece uma composição imunogênica obtida por um método compreendendo a) cultivo de uma bactéria micoplasma selecionada do grupo que consiste em m. hyorhinis, m. hyopneumoniae e m. hyosynoviae em um sistema celular reduzido em soro, eucariótico; b) obtenção de um antígeno de tal bactéria micoplasma; e c) adição de um veículo farmaceuticamente aceitável.
BR112015015199-0A 2012-12-28 2013-12-20 Composição imunogênica compreendendo antígenos de micoplasma e uso BR112015015199B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261747026P 2012-12-28 2012-12-28
US61/747,026 2012-12-28
PCT/US2013/076803 WO2014105671A1 (en) 2012-12-28 2013-12-20 Immunogenic composition comprising mycoplasma antigens

Publications (2)

Publication Number Publication Date
BR112015015199A2 true BR112015015199A2 (pt) 2017-07-11
BR112015015199B1 BR112015015199B1 (pt) 2022-09-06

Family

ID=49956440

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015199-0A BR112015015199B1 (pt) 2012-12-28 2013-12-20 Composição imunogênica compreendendo antígenos de micoplasma e uso

Country Status (20)

Country Link
US (2) US9878027B2 (pt)
EP (2) EP2938356B1 (pt)
JP (2) JP6195630B2 (pt)
KR (1) KR102355614B1 (pt)
CN (2) CN104981252B (pt)
AR (1) AR094296A1 (pt)
AU (2) AU2013370982C9 (pt)
BR (1) BR112015015199B1 (pt)
CA (1) CA2896293C (pt)
CL (1) CL2015001659A1 (pt)
DK (1) DK2938356T3 (pt)
EA (1) EA038206B1 (pt)
ES (1) ES2808673T3 (pt)
MX (1) MX2015007729A (pt)
MY (1) MY174818A (pt)
PH (1) PH12015501335A1 (pt)
SG (1) SG11201505086QA (pt)
TW (1) TWI633890B (pt)
UA (1) UA121097C2 (pt)
WO (1) WO2014105671A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2938356B1 (en) * 2012-12-28 2020-05-13 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
CN104968365B (zh) * 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
CN104730256B (zh) * 2015-04-03 2016-05-04 江苏省农业科学院 用于检测支原体抗体的组合物及其应用
CN113461791B (zh) * 2021-06-23 2022-05-03 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0493在制备猪鼻支原体或其抗体检测试剂盒中的应用
CN113444157B (zh) * 2021-06-23 2022-05-13 湖北省农业科学院畜牧兽医研究所 猪鼻支原体外膜蛋白Mhr_0461在制备猪鼻支原体或其抗体检测试剂盒中的应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
GB1074920A (en) 1965-04-21 1967-07-05 Pfizer & Co C Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es) * 1966-07-11 1968-09-01 Research Corp Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (pt) 1972-10-05 1980-10-18
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US6537552B1 (en) * 1999-10-19 2003-03-25 Iowa State University Research Foundation Vaccine adjuvant
KR100797547B1 (ko) 2000-03-03 2008-01-24 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
CA2452666A1 (en) * 2001-07-02 2003-01-16 Pfizer Products Inc. Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
ATE412426T2 (de) * 2001-07-02 2008-11-15 Pfizer Prod Inc Vakzination in einer dosis mit i mycoplasma hyopneumoniae /i
TWI238721B (en) * 2003-06-20 2005-09-01 Animal Technology Inst Taiwan Swine enzootic vaccine, its producing method and usage
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
WO2006084364A1 (en) * 2005-02-09 2006-08-17 Magna International Inc. Method of manufacturing a semi-structural panel
WO2006095431A1 (ja) * 2005-03-10 2006-09-14 Kyoritsu Seiyaku Corporation 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
EP2615167A1 (en) * 2006-09-15 2013-07-17 MedImmune, LLC Method for eliminating DNA contaminants from viral preparations
US20090068231A1 (en) 2007-09-11 2009-03-12 Wyeth Live attenuated mycoplasma strains
AR069087A1 (es) * 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
MX2010005014A (es) 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
US20090317423A1 (en) * 2008-01-23 2009-12-24 Boehringer Ingelheim Vetmedica, Inc. Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
WO2009142086A1 (ja) * 2008-05-23 2009-11-26 学校法人久留米大学 マイコプラズマ感染症用ワクチン組成物
DK2310046T3 (da) * 2008-06-27 2016-04-25 Zoetis Services Llc Hidtil ukendte adjuvanssammensætninger
MX2011012362A (es) 2009-05-19 2012-04-19 Bioproperties Pty Ltd Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usoz de la misma.
US20110150770A1 (en) * 2009-12-18 2011-06-23 Boehringer Ingelheim Vetmedica, Inc. Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
AT509622A1 (de) * 2010-04-08 2011-10-15 Greiner Bio One Gmbh Verfahren und kit zur trennung viraler und prokaryontischer von eukaryontischen nukleinsäuren
CN102258776B (zh) 2011-07-07 2013-07-10 普莱柯生物工程股份有限公司 猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
EP2938356B1 (en) * 2012-12-28 2020-05-13 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
CN104968365B (zh) 2012-12-28 2018-04-03 勃林格殷格翰动物保健有限公司 支原体疫苗的制备方法
CA3005608C (en) * 2013-09-19 2020-06-30 Zoetis Services Llc Water-in-oil emulsions comprising immunostimulatory oligonucleotides
AU2015241107B2 (en) * 2014-04-03 2019-10-03 Boehringer Ingelheim Animal Health USA Inc. Porcine epidemic diarrhea virus vaccine

Also Published As

Publication number Publication date
AU2013370982C1 (en) 2019-01-17
BR112015015199B1 (pt) 2022-09-06
JP6195630B2 (ja) 2017-09-13
JP2016505603A (ja) 2016-02-25
CN110227151A (zh) 2019-09-13
TW201438733A (zh) 2014-10-16
CA2896293C (en) 2023-11-07
CN104981252A (zh) 2015-10-14
CL2015001659A1 (es) 2016-09-16
EA201500700A1 (ru) 2016-01-29
AR094296A1 (es) 2015-07-22
CN104981252B (zh) 2019-06-18
AU2013370982A1 (en) 2014-07-03
AU2013370982B2 (en) 2018-02-15
CA2896293A1 (en) 2014-07-03
JP2017197568A (ja) 2017-11-02
US9878027B2 (en) 2018-01-30
JP6456437B2 (ja) 2019-01-23
EP3730148A3 (en) 2021-03-24
ES2808673T3 (es) 2021-03-01
EP3730148A2 (en) 2020-10-28
US10758602B2 (en) 2020-09-01
MY174818A (en) 2020-05-17
EA038206B1 (ru) 2021-07-23
MX2015007729A (es) 2015-09-07
KR102355614B1 (ko) 2022-01-27
AU2013370982C9 (en) 2019-01-24
AU2018202698A1 (en) 2018-06-14
UA121097C2 (uk) 2020-04-10
KR20150100919A (ko) 2015-09-02
WO2014105671A1 (en) 2014-07-03
AU2018202698B2 (en) 2020-02-13
EP2938356B1 (en) 2020-05-13
TWI633890B (zh) 2018-09-01
DK2938356T3 (da) 2020-07-27
US20180125957A1 (en) 2018-05-10
US20140186393A1 (en) 2014-07-03
EP2938356A1 (en) 2015-11-04
PH12015501335A1 (en) 2015-09-02
SG11201505086QA (en) 2015-07-30

Similar Documents

Publication Publication Date Title
BR112015015199A2 (pt) composição imunogênica compreendendo antígenos de micoplasma
BR112015012711A2 (pt) método de produção de uma vacina de mycoplasma
PH12014502250A1 (en) Mycoplasma hyopneumoniae vaccine
EA035991B9 (ru) Новый полисахарид и его применения
BR112013026929A2 (pt) composição e método para intensificação de uma resposta imune
MX2013013111A (es) Composicion inmunogenica que presenta antigeno multiple, y metodos y usos de la misma.
MX2014010020A (es) Composicion que comprende productos de fermantacion de bacillus subtilis.
BR112015023084A2 (pt) anticorpo anti-cd25 monoclonal ou um fragmento ligante anti-cd25 de um anticorpo monoclonal, conjugado de anticorpo-droga, composição farmacêutica, ácido nucleico, vetor, célula hospedeira procariota e eucariota, método para a produção de um anticorpo anti-cd25 ou fragmento ligante anti-cd25, e, uso de um anticorpo anti-cd25 monoclonal de um conjugado anticorpo-droga ou de uma composição farmacêutica
BR112017002183A2 (pt) conjugado, composição farmacêutica, e, método para aumentar uma resposta imune em um mamífero
MX349119B (es) Vacuna de virus de dengue inactivado.
CO6361948A2 (es) Uso de antigeno de mycoplasma bovis
MY160639A (en) Immunization compositions and methods
UY31437A1 (es) Vacuna de mycoplasma bovis y métodos de uso de la misma
NZ741342A (en) Daptomycin formulations and uses thereof
BRPI0817334A8 (pt) Bactéria mycoplasma gallisepticum atenuadas viva, composição para vacina, uso da dita composição e processo para identificação de clones mycoplasma gallisepticum atenuados
BR112016010427A2 (pt) proteína para prevenir infecção por mycoplasma spp., composição para prevenir infecção por mycoplasma spp., vetor de expressão, e método para preparar antígeno solúvel
MX2018007950A (es) Vacuna multivalente m hyo y usos de la misma.
BR112015023332A2 (pt) Toxóide, composições e método relacionados
PL404247A1 (pl) Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis
PH12014502015A1 (en) Novel veterinary vaccine
BR112017012537A2 (pt) copolímero de álcool polimetalílico e corpo moldado que contém o mesmo e método de produção de copolímero de álcool polimetalílico
MX2016000195A (es) Oligosacaridos sinteticos para vacuna de p. aeruginosa.
BR112015012515A2 (pt) métodos para a indução de anticorpos
BR112015011944A8 (pt) linhagem bacteriana atenuada estável, seus usos e método para sua geração, composição de vacina
WO2014159592A3 (en) Modified hyaluronan and uses thereof in cancer treatment

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2013, OBSERVADAS AS CONDICOES LEGAIS